January 26th Lunch & Learn Event on Sjogren’s Syndrome PDF Print E-mail
Thursday, 07 January 2010 12:16
For those of you in the state of Texas, Northwest Rheumatology, a division of Northwest Diagnostic Clinic, will host a free Lunch & Learn event on Sjogren’s Sydrome: The Forgotten Disease on Tuesday, Jan. 26, from 11:45 a.m. – 1 p.m. at the South Montgomery County Woodlands Chamber of Commerce Board Room.

Dr. Tamar Brionez of Northwest Rheumatology will speak on the definition, symptoms and therapeutics of Sjogren’s Syndrome, a disease often undiagnosed or misdiagnosed due to symptoms that mimic other medical conditions. This Lunch & Learn is the second in a quarterly series that will address a variety of health topics.

“This is a great topic to discuss,” said Dr. Brionez. “The lunch will be very informative and I look forward to addressing the questions and concerns commonly associated with Sjogren’s Syndrome. I am excited to be the next speaker in this series.”

The event is free and open to the public. Reservations are required and must be made by Friday, Jan. 22.

With four physicians on staff, Northwest Rheumatology specializes in the treatment of Rheumatoid Arthritis, Scleroderma, Sjogren’s Syndrome, Psoriatic Arthritis, Lupus and other autoimmune diseases, as well as Osteoporosis and Osteoarthritis. With offices in The Woodlands and Houston, the clinic offers several areas of expertise including family practice, internal medicine and rheumatology, as well as on-site ancillary services such as CT, MRI, nuclear medicine, ultrasound, bone density testing, infusion and laboratory services.

For more information, do click here.
 
More articles :

» Calcium Deposits Under the Skin

Numerous health effects or conditions are associated with calcinosis or calcium deposits under the skin. According to the , calcinosis is the medical term for calcium deposits that can form under the skin or in the muscles. Calcium deposits in these...

» Egr-1: A Target for Scleroderma Therapy

Two separate research groups funded by the (NIAMS) have discovered that the molecule EGR-1 (early growth response 1), which regulates gene expression, plays a central role in the development of fibrosis, a condition in which organ-supporting tissue...

» HLA Class II Haplotype and Autoantibody Associations in Children

L. R. Wedderburn; N. J. McHugh; H. Chinoy; R. G. Cooper; F. Salway; W. E. R. Ollier; L. J. McCann; H. Varsani; J. Dunphy; J.North; J. E. DavidsonPosted: 12/19/2007; Rheumatology. 2007;46(12):1786-1791. © 2007 Oxford University PressObjectives: To...

» Endothelin Drugs Benefit Those With Pulmonary Hypertension

Breaking news from has reported that recent research to block the effects of endothelin, a powerful substance that constricts blood vessels and stimulates cell growth, has led to successful treatment of and provides hope for treating other chronic...

» Cell Therapy Yields Promising Results For Scleroderma Treatment

Cytori Therapeutics, Inc. provided preliminary data from a study evaluating a potential treatment for Scleroderma based on the company's cell therapy. The investigator-funded, open-label, pilot study is being conducted on patients with Cutaneous...

» A Guide to Managing Your Child’s Scleroderma

Although localized and systemic sclerodermas are very different diseases, living with a child who has either disease represents a special set of problems. Indeed the issues faced by the parents of children with most chronic diseases are the same....